Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.
Advanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, patient access to these therapies may change without continued investment in the UK's cell therapy infrastructure.
Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Marc Bonaca, MD, PHH, FACC discussed semaglutide’s potential benefits for non-diabetic patients with peripheral artery disease.
Students are being exposed to new patient experiences through collaboration with practitioners.
The TJC and IHI advocate for medication reconciliation at all transitions of care.
Although quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.
The HERCULES trial demonstrates tolebrutinib's potential to slow disability progression in non-relapsing secondary progressive multiple sclerosis, offering a new treatment option for patients with limited therapeutic choices.
This medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.
Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.
John Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.
An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.
A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
More drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.
Incorporating AI into pharmacy education is crucial to training on its appropriate use.
Holistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.
The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Working for the USPHS offers unique compensation and quality-of-life benefits.
There are no clearly defined, widely accepted clinical pharmacist metrics.
Zahra Mahmoudjafari, PharmD, BCOP, FHOPA, shared insight from the HOPA Annual Meeting 2025.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.
In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Gender-affirming care and inclusive practices are essential for health equity.
These facilities provide significant value to payers and patients.